TAB2 deletions and variants cause a highly recognisable syndrome with mitral valve disease, cardiomyopathy, short stature and hypermobility

Aafke Engwerda, Erika K. S. M. Leenders, Barbara Frentz, Paulien A. Terhal, Katharina Lohner, Bert B. A. de Vries, Trijnie Dijkhuizen, Yvonne J. Vos, Tuula Rinne, Maarten P. van den Berg, Marc T. R. Roofthooft, Patrick Deelen, Conny M. A. Van Ravenswaaij-Arts, Wilhelmina S. Kerstjens-Frederikse*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Deletions that include the gene TAB2 and TAB2 loss-of-function variants have previously been associated with congenital heart defects and cardiomyopathy. However, other features, including short stature, facial dysmorphisms, connective tissue abnormalities and a variable degree of developmental delay, have only been mentioned occasionally in literature and thus far not linked to TAB2. In a large-scale, social media-based chromosome 6 study, we observed a shared phenotype in patients with a 6q25.1 deletion that includes TAB2. To confirm if this phenotype is caused by haploinsufficiency of TAB2 and to delineate a TAB2-related phenotype, we subsequently sequenced TAB2 in patients with matching phenotypes and recruited patients with pathogenic TAB2 variants detected by exome sequencing. This identified 11 patients with a deletion containing TAB2 (size 1.68-14.31 Mb) and 14 patients from six families with novel truncating TAB2 variants. Twenty (80%) patients had cardiac disease, often mitral valve defects and/or cardiomyopathy, 18 (72%) had short stature and 18 (72%) had hypermobility. Twenty patients (80%) had facial features suggestive for Noonan syndrome. No substantial phenotypic differences were noted between patients with deletions and those with intragenic variants. We then compared our patients to 45 patients from the literature. All literature patients had cardiac diseases, but syndromic features were reported infrequently. Our study shows that the phenotype in 6q25.1 deletions is caused by haploinsufficiency of TAB2 and that TAB2 is associated not just with cardiac disease, but also with a distinct phenotype, with features overlapping with Noonan syndrome. We propose the name "TAB2-related syndrome".

Original languageEnglish
Number of pages8
JournalEuropean Journal of Human Genetics
DOIs
Publication statusE-pub ahead of print - 30-Aug-2021

Keywords

  • CONGENITAL HEART-DEFECTS
  • GROWTH FAILURE
  • MICRODELETION
  • DELINEATION
  • DYSPLASIA
  • TAK1

Cite this